Thrivent Financial for Lutherans Boosts Position in SPDR S&P Biotech ETF $XBI

Thrivent Financial for Lutherans raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 66.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 137,863 shares of the exchange traded fund’s stock after acquiring an additional 54,966 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.21% of SPDR S&P Biotech ETF worth $16,809,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Cornerstone Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 1.6% in the fourth quarter. Cornerstone Wealth Management LLC now owns 7,727 shares of the exchange traded fund’s stock worth $942,000 after buying an additional 123 shares during the last quarter. Pinnacle Associates Ltd. increased its holdings in SPDR S&P Biotech ETF by 6.9% during the fourth quarter. Pinnacle Associates Ltd. now owns 11,766 shares of the exchange traded fund’s stock valued at $1,435,000 after buying an additional 760 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich increased its holdings in SPDR S&P Biotech ETF by 18.9% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 12,706 shares of the exchange traded fund’s stock valued at $1,549,000 after buying an additional 2,023 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $132,000. Finally, Navalign LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $48,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $127.67 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $78.00 and a 1-year high of $139.19. The company’s fifty day simple moving average is $129.46 and its 200-day simple moving average is $124.61. The stock has a market capitalization of $8.15 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.